Dose-related differences in the pharmacodynamic and toxicologic response to a novel hyperglycosylated analog of recombinant human erythropoietin in Sprague-Dawley rats with similarly high hematocrit. - Andrews DA; Boren BM; Turk JR; Boyce RW; He YD; Hamadeh HK; Mytych DT; Barger TE; Salimi-Moosavi H; Sloey B; Elliott S; McElroy P; et al. (Toxicologic pathology, 2014)